Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
07/01/2009 | CN101468992A Isoquinolinium compound, pharmaceutical composition containing the same, preparation and use thereof |
07/01/2009 | CN101468991A Isoquinolinium compound, pharmaceutical composition containing the same, preparation and use thereof |
07/01/2009 | CN101468990A Isoquinolinium compound, pharmaceutical composition containing the same, preparation and use thereof |
06/30/2009 | US7553841 Amino cyclobutylamide modulators of chemokine receptor activity |
06/25/2009 | WO2009078423A1 Fused tricyclic compound having aldose reductase inhibitory activity |
06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
06/25/2009 | US20090163716 Spirocyclic cyclohexane compounds |
06/25/2009 | US20090163527 Spiropiperidines for use as tryptase inhibitors |
06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
06/24/2009 | EP1954698B1 Spirocyclic compounds as hdac inhibitors |
06/24/2009 | CN100503600C Pesticidal heterocycles |
06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
06/23/2009 | US7550588 Homotropanes with central nervous system activity |
06/23/2009 | US7550570 4,7-dichlororhodamine dyes labeled polynucleotides |
06/23/2009 | US7550498 Antiinflammatory agents, analgesics; e.g. Dimethyl-(2-[2-(8-thia-1,2-diaza-dibenzo[e,h]azulene-1-yl)-ethoxy]-ethyl)-amine and chemical intermediates; treating TNF-related disorders such as rheumatoid arthritis |
06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
06/23/2009 | US7550458 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
06/23/2009 | US7550431 Spatially-defined macrocycles incorporating peptide bond surrogates |
06/23/2009 | CA2300148C Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
06/18/2009 | WO2009075784A1 Organic compounds |
06/18/2009 | WO2009074674A2 Trisubstituted piperidines as renin inhibitors |
06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
06/18/2009 | WO2009025919A3 5-propargyl-pyrimidine derivatives as inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties |
06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
06/18/2009 | WO2007027532A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
06/18/2009 | US20090156821 Quinazoline compounds |
06/18/2009 | US20090156803 Condensed furan compounds |
06/18/2009 | US20090156630 Anti-tumour polycyclic carboxamides |
06/18/2009 | US20090156626 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
06/18/2009 | US20090156593 Spirocyclic Azaindole Derivatives |
06/18/2009 | US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors |
06/18/2009 | US20090153034 Carbazole-containing materials in phosphorescent light emittinig diodes |
06/18/2009 | CA2708570A1 Organic compounds |
06/18/2009 | CA2707349A1 Organic compounds useful as inhibitors of phosphodiesterase 1 |
06/17/2009 | EP2070537A1 Crystalline polymorphs of topotecan hydrochloride and methods for the preparation thereof |
06/17/2009 | EP2069355A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
06/17/2009 | EP2069354A1 Aza-benzofuranyl compounds and methods of use |
06/17/2009 | EP1866306B1 Imidazopyridine derivatives useful as inos inhibitors |
06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
06/17/2009 | EP1566384B1 Novel azole derivatives |
06/17/2009 | EP1499616B1 Heterocyclic compounds |
06/17/2009 | CN101460502A Bicyclic enamino(thio)carbonyl compounds |
06/17/2009 | CN101456863A Novel LXR agonist as well as preparation method and application thereof |
06/17/2009 | CN100500669C Salviolic acid berberine compound salt, its preparation method and application |
06/17/2009 | CN100500668C Geldanamycin derivative and its preparing method and use for preparing medicine |
06/16/2009 | US7547785 Hydrogenating camptothecin in presence of hydrogenation catalyst and thioanisole to form 10-hydroxycamptothecin and reacting 10-hydroxy camptothecin with dimethylamine and formaldehyde in presence of acetic acid to form topotecan acetate; anti-tumor agent with topoisomerase I-inhibitory activity |
06/16/2009 | US7547782 Met kinase inhibitors |
06/16/2009 | US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
06/16/2009 | US7547708 N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereof |
06/16/2009 | US7547707 Spirocyclic cyclohexane compounds |
06/16/2009 | US7547706 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
06/16/2009 | US7547697 Alkyl-pyridazine derivatives as 11b-HSD1 inhibitors |
06/16/2009 | US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands |
06/16/2009 | US7547660 Phenyl-substituted 4-hydroxy-tetrahydropyridones |
06/16/2009 | CA2444818C Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
06/16/2009 | CA2284802C Substituted isoquinolines as ultra short acting neuromuscular blockers |
06/16/2009 | CA2264750C Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
06/11/2009 | WO2009073779A1 Gamma secretase modulators |
06/11/2009 | WO2009073462A1 Process for the preparation of 5-cyclopropyl-5, 11-dihydro (1) benzoxepino (3, 4-b) -pyridin-5-ol using tmeda |
06/11/2009 | WO2009071476A1 Isoxazolo-pyridine derivatives |
06/11/2009 | WO2009032123A3 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
06/11/2009 | US20090149661 N-Substituted 3,4-Alkylenedioxypyrroles, Ester Substituted Dihydroxypyrroles and Methods for Synthesis of These Pyrroles |
06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
06/11/2009 | CA2707722A1 Gamma secretase modulators |
06/11/2009 | CA2707648A1 Isoxazolo-pyridine derivatives |
06/10/2009 | EP2067779A1 Tiotropium salts, method for their production and medicinal formulas containing them |
06/10/2009 | EP2067771A1 Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds |
06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
06/10/2009 | EP1601673B1 Fused heterocycles and uses thereof |
06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
06/10/2009 | CN101450949A Chemical semi-synthetic process of 10-hydroxycamptothecin |
06/10/2009 | CN100497342C Preparation process of 1,8-disubstituent-1,3,4,9-tetrahydropyran (3,4-b)-indolyl-1-acetate |
06/10/2009 | CN100496244C Nodulisporic acid derivative spot-on formulations for killing parasites |
06/09/2009 | US7544814 lactam fermentation products; pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane; based on marine microorganisms structures; cytotoxicity, NF- kappa B inhibition, and caspase-like and trypsin-like proteasome inhibition |
06/09/2009 | US7544801 7-Ethyl-1,2,6,7-tetrahydrocampotothecin is oxidized with an oxidizing agent selected from iodosobenzene, an ester of iodosobenzene, sodium periodate, potassium periodate, potassium peroxodisulfate and ammonium peroxodisulfate, in a saturated aliphatic monocarboxylic acid solvent; no colored by-products |
06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
06/09/2009 | US7544697 Pyrazolopyridines and analogs thereof |
06/09/2009 | US7544693 Spirofuropyridine aryl derivatives |
06/09/2009 | US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders |
06/09/2009 | US7544680 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide (CGRP) receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma |
06/04/2009 | WO2009070556A1 Process improvement |
06/04/2009 | WO2009069668A1 Agent for increasing the expression of malignant melanoma antigen, and use thereof |
06/04/2009 | WO2009069610A1 Fused indane compound |
06/04/2009 | WO2009069589A1 Novel naphthyridine derivative monohydrate and method for producing the same |
06/04/2009 | US20090143588 Quartz glass micro-photoreactor and synthesis of 10-hydroxycamptothecin and 7-alkyl 10-hydroxycamptothecin |
06/04/2009 | US20090143581 Synthesis of avrainvillamide, strephacidin b, and analogues thereof |
06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
06/04/2009 | US20090143432 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof |
06/04/2009 | US20090143422 P38 inhibitors and methods of use thereof |
06/04/2009 | US20090143412 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
06/04/2009 | US20090143411 Thiophens and Their Use as Anti-Tumor Agents |
06/04/2009 | US20090143399 Protein Kinase Inhibitors |
06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
06/04/2009 | US20090143345 Thioamide derivatives as progesterone receptor modulators |
06/04/2009 | CA2706929A1 Novel naphthyridine derivative monohydrate and method for producing the same |
06/04/2009 | CA2706171A1 Fused indane compound |
06/03/2009 | EP2065387A2 Quartz glass micro-photoreactors and synthesis of 10 hydroxycamptothecin and 7-alkyl-10-hydroxycamptothecin |